It is approved by the FDA and EMA to support weight loss in people with BMI 30 kg/m 2 or 27 kg/m 2 and obesity-related co-morbidity [9, 17]
These benefits persist through year five and appear to strengthen with continued medication adherence, independent of weight loss alone
How SMGT-GLP-1 Transforms Your Health SMGT-GLP-1 is a multi-functional treatment with proven benefits in: Weight Loss Suppresses appetite, slows gastric emptying, and promotes fat burning
The more you can share with your provider, the better they can help keep you safe
The department also did not provide a date for the launch of the new regional obesity management service, which had been due to open in early 2026
Some patients may begin to see results in five weeks, while it may take up to 3 months for others